LCD and Article Updates for April/May 2024

Billing and Coding Articles

Billing and Coding: Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin and Non-Hodgkin Lymphoma with B-cell or T-cell Origin (A59311)

Based on CR13507 the following ICD-10-PCS codes were added: 30233U2, 30233U3, 30243U2, 30243U3, effective 10/1/2019.

Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound (A58893)

Per Transmittal 12501 (CR 13529) - Quarterly Update to the Medicare Physician Fee Schedule Database (MPFSDB) - April 2024 Update, Healthcare Common Procedure Coding System HCPCS code Q4244 has been deleted and Q4310 has been added.

Billing and Coding: Ranibizumab and biosimilars, Aflibercept, Aflibercept HD, Brolucizumab-dbll and Faricimab-svoa (A52451)

Per Transmittal 12501 (CR 13529) - Quarterly Update to the Medicare Physician Fee Schedule Database (MPFSDB) - April 2024 Update, HCPCS code C9161 has been deleted and replaced with J0177.

Posted 4/29/2024